CGEN Q3 2023 Earnings — Compugen Ltd. Revenue & Financial Results | Market Cap Arena

CGENCompugen Ltd.

$202M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$11M

Net Income

-$10M

EPS (Diluted)

$-0.11

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

$0

Free Cash Flow

$0

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$68M

Total Liabilities

$14M

Stockholders' Equity

$53M

Cash & Equivalents

$48M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$11M	-$12M	+13.0%
Net Income	-$10M	-$12M	+16.1%